Software Innovations in Clinical Drug Development and Safety

Software Innovations in Clinical Drug Development and Safety

Noted as an IGI Global Core Reference Title in Medicine & Healthcare for 2019.

Partha Chakraborty (Cognizant Technology Solutions, India) and Amit Nagal (GVK Bioscience, India)
Release Date: October, 2015|Copyright: © 2016 |Pages: 305
DOI: 10.4018/978-1-4666-8726-4
ISBN13: 9781466687264|ISBN10: 1466687266|EISBN13: 9781466687271
Hardcover:
Available
$225.00
TOTAL SAVINGS: $225.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
E-Book:
(Multi-User License)
Available
$202.50
List Price: $225.00
10% Discount:-$22.50
TOTAL SAVINGS: $22.50
Benefits
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • ePub with PDF download
Hardcover +
E-Book:
(Multi-User License)
Available
$270.00
TOTAL SAVINGS: $270.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • ePub with PDF download
OnDemand:
(Individual Chapters)
Available
$37.50
TOTAL SAVINGS: $37.50
Benefits
  • Purchase individual chapters from this book
  • Immediate PDF download after purchase or access through your personal library
Description & Coverage
Description:

In light of the rising cost of healthcare and the overall challenges associated with delivering quality care to patients across regions, scientists and pharmacists are exploring new initiatives in drug discovery and design. One such initiative is the adoption of information technology and software applications to improve healthcare and pharmaceutical processes.

Software Innovations in Clinical Drug Development and Safety is a comprehensive resource analyzing the integration of software engineering for the purpose of drug discovery, clinical trials, genomics, and drug safety testing. Taking a multi-faceted approach to the application of computational methods to pharmaceutical science, this publication is ideal for healthcare professionals, pharmacists, computer scientists, researchers, and students seeking the latest information on the architecture and design of software in clinical settings, the impact of clinical technologies on business models, and the safety and privacy of patients and patient data.

This timely resource features a well-rounded discussion on topics pertaining to the integration of computational methods in pharmaceutical science and practice including, the impact of software integration on business models, patient safety concerns, software architecture and design, and data security.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Clinical Research
  • Clinical Trials
  • Data Management
  • Drug Discovery
  • Drug Response
  • Pharmacoinformatics
  • Software Development
  • System Validation
Reviews and Testimonials

Contributed by information technology, informatics, and other specialists from India, Saudi Arabia, the UK, and the US, the 13 articles in this volume discuss the integration of software innovations in drug discovery, clinical trials, genomics, and drug safety testing. They address the business processes of clinical trials and drug safety, and areas of improvement through software innovation, including the application of computer systems, data warehouse and data virtualization techniques, metadata repository and master data management, and more.

– ProtoView Book Abstracts (formerly Book News, Inc.)

This title is one in a series on innovations that enable faster and safer patient care. Not only relevant to pharmacy informatics, this book covers topics that will assist those in nursing informatics, clinical technology, biomedicine, and other innovative healthcare technologies. It goes beyond just a definition for various technologies, providing detailed information to support informatics professionals. This is a useful book for an informatics educational program that is also relevant to informatics in practice.

– Barbara L Giacomelli, PharmD., MBA, Doody's Review Service
Table of Contents
Search this Book:
Reset
Editor/Author Biographies
Partha Chakraborty is the Sr, Director & Head of Global Delivery R&D Practice in Cognizant Life Sciences (www.cognizant.com). He is a BTech from Indian Institute of Technology (IIT), Kharagpur. He has worked with large healthcare providers and multiple large global pharmaceuticals globally and led IT transformation in Clinical & Safety as well as the implementation of critical engagements. He has presented his point of view in FDA Science Congress, CDISC Interchange, International Society of Pharmacovigilance (ISOP) and DIA. He is instrumental in creating the 1st certificate course, in Pharmacovigilance in India, launched by Symogen, UK. He has written a chapter, called Role of Information Technology on Drug Safety in a recently published book Elements of Pharmacovigilance; Statistical Methods Applied in Drug Safety in a recently published book Handbook of Research on Pharmacoinformatics.
Amit Nagal is a bioinformatics scientist who has worked with large scale data management and analysis on HPC clusters. He is involved in developing tools/databases and giving bioinformatics approaches to drive experimental discoveries.
Peer Review Process
The peer review process is the driving force behind all IGI Global books and journals. All IGI Global reviewers maintain the highest ethical standards and each manuscript undergoes a rigorous double-blind peer review process, which is backed by our full membership to the Committee on Publication Ethics (COPE). The full publishing process and peer review are conducted within the IGI Global eEditorial Discovery® online submission system and on average takes 30 days. Learn More
Ethics & Malpractice
IGI Global affirms that ethical publication practices are critical to the successful development of knowledge. Therefore, it is the policy of IGI Global to maintain high ethical standards in all publications. These standards pertain to all books, journals, chapters, and articles accepted for publication. This is in accordance with standard scientific principles and IGI Global’s position as a source of scientific knowledge. Learn More
Archiving
All of IGI Global's content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global published content is available in IGI Global's InfoSci® platform.